Trial Profile
The effect of Sitagliptin on Coronary Flow Reserve in Type 2 Diabetic Patients with Coronary Artery Disease.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2011
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 15 Mar 2011 New trial record